Developing a Case-Based Blended Learning Ecosystem to Optimize Precision Medicine: Reducing Overdiagnosis and Overtreatment
暂无分享,去创建一个
Binod Dhakal | Vivek Podder | Gousia Ummae Salma Shaik | Kaushik Sundar | Madhava Sai Sivapuram | Vijay Kumar Chattu | Rakesh Biswas | V. Chattu | R. Biswas | V. Podder | B. Dhakal | M. Sivapuram | K. Sundar | Gousia Ummae Salma Shaik
[1] J. Gartner,et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer , 2018, Nature Medicine.
[2] Nicolas Servant,et al. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. , 2015, The Lancet. Oncology.
[3] J. T. McGautry,et al. Medical education. , 1978, Cutis.
[4] G. Dy,et al. Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options , 2016, Cancer biology & medicine.
[5] Joachim P. Sturmberg,et al. The User Driven Learning Environment , 2013 .
[6] Alessandro Testori,et al. The role of BRAF V600 mutation in melanoma , 2012, Journal of Translational Medicine.
[7] A. Chen,et al. An overview of the NCI precision medicine trials-NCI MATCH and MPACT. , 2015, Chinese clinical oncology.
[8] B. Djulbegovic,et al. Evidence-based medicine meets person-centred care: a collaborative perspective on the relationship. , 2015, Journal of evaluation in clinical practice.
[9] E. Lindsay. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct , 2018 .
[10] Carmel M. Martin,et al. User-Driven Healthcare and Narrative Medicine: Utilizing Collaborative Social Networks and Technologies , 2010 .
[11] Richard L Kravitz,et al. Harnessing experience: exploring the gap between evidence-based medicine and clinical practice. , 2008, Journal of evaluation in clinical practice.
[12] R. Raz. Urinary Tract Infection in Postmenopausal Women , 2011, Korean journal of urology.
[13] Stefan V. Pantazi,et al. Case-based medical informatics , 2004, BMC Medical Informatics Decis. Mak..
[14] Lisa M Behnke,et al. A targeted approach to reducing overutilization: use of percutaneous coronary intervention in stable coronary artery disease. , 2013, Population health management.
[15] Sudhir Srivastava,et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. , 2014, The Lancet. Oncology.
[16] K. Patel,et al. Detection of Circulating Thyroid Tumor DNA in Patients with Thyroid Nodules , 2015 .
[17] Pascal Pommier,et al. Optimizing clinical practice with case-based reasoning approach. , 2008, Journal of evaluation in clinical practice.
[18] P. A.,et al. comparative effectiveness research collaboration and precision medicine , 2015, Annals of neurosciences.
[19] R. Biswas,et al. Understanding Clinical Complexity Through Conversational Learning in Medical Social Networks: Implementing User-Driven Health Care , 2013 .
[20] Igor Jurisica,et al. Case-Based Reasoning for Biomedical Informatics and Medicine , 2014 .
[21] M. Amiot,et al. Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma. , 2017, Blood.
[22] T. Fleming,et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.
[23] A. Hackshaw,et al. Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET). , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] P. Kerkar,et al. Appropriateness of elective percutaneous coronary intervention and impact of government health insurance scheme — A tertiary centre experience from Western India , 2017, Indian heart journal.
[25] G. Dy,et al. Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options@@@Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options , 2016 .
[26] S. Saeed,et al. Comparison of Fine Needle Aspiration Cytology and Thyroid Scan in Solitary Thyroid Nodule , 2011, Pathology research international.
[27] S. Brownlee,et al. Evidence for overuse of medical services around the world , 2017, The Lancet.
[29] L. Klotz,et al. Cancer overdiagnosis and overtreatment , 2012, Current opinion in urology.
[30] P R Shankar,et al. Initiating and strengthening medical student research: time to take up the gauntlet. , 2006, Kathmandu University medical journal.
[31] F. Scheele,et al. Innovator’s prescription , 2015 .
[32] A. D. Van den Abbeele,et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. , 2002, The New England journal of medicine.
[33] Jai Ganesh Udayasankaran,et al. From Dyadic Ties to Information Infrastructures: Care-Coordination between Patients, Providers, Students and Researchers , 2015, Yearbook of Medical Informatics.
[34] R. Herbst,et al. Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer. , 2016, JAMA oncology.
[35] Martin C. Müller,et al. Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV. , 2015, Blood.
[36] David J Hunter,et al. Uncertainty in the Era of Precision Medicine. , 2016, The New England journal of medicine.
[37] L. Klotz,et al. Overtreatment in cancer – is it a problem? , 2016, Expert opinion on pharmacotherapy.
[38] Amy Price,et al. Medical Students Meet User Driven Health Care for Patient Centered Learning in Clinical Medicine , 2014 .
[39] R. Biswas,et al. Person-centered healthcare in the information age: Experiences from a user driven healthcare network , 2013 .
[40] F. Collins,et al. A new initiative on precision medicine. , 2015, The New England journal of medicine.